CLINICAL_TRIALS
trial_result
· 2013-12-30
Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy and safety of tiotropium in children aged 6 to 11 with moderate asthma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-12-30